title: The 6 day subrenal capsule assay is of no value with primary surgical explants from gastric cancer.
authors.forename: D
authors.initials: D
authors.lastname: Cunningham
authors.forename: A
authors.initials: A
authors.lastname: Jack
authors.forename: D F
authors.initials: DF
authors.lastname: McMurdo
authors.forename: M
authors.initials: M
authors.lastname: Soukop
authors.forename: C S
authors.initials: CS
authors.lastname: McArdle
authors.forename: D C
authors.initials: DC
authors.lastname: Carter
authors.forename: S B
authors.initials: SB
authors.lastname: Kaye
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000818:Animals; D002945:Cisplatin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D015251:Epirubicin; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007668:Kidney; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D015251:Epirubicin; D004317:Doxorubicin; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate